MIC distributions for amphotericin B, fluconazole, itraconazole, voriconazole, flucytosine and anidulafungin and 35 uncommon pathogenic yeast species from the UK determined using the CLSI broth microdilution method

Candida auris isolates of the Southern Asian and South African lineages exhibit different phenotypic and antifungal susceptibility profiles in vitro

(2019) Adrien Szekely et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Fluconazole Resistance in Isolates of Uncommon Pathogenic Yeast Species from the United Kingdom

(2019) Andrew M. Borman et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Five-Year National Surveillance of Invasive Candidiasis: Species Distribution and Azole Susceptibility from the China Hospital Invasive Fungal Surveillance Net (CHIF-NET) Study

(2018) Meng Xiao et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Are In Vitro Susceptibilities to Azole Antifungals Predictive of Clinical Outcome in the Treatment of Candidemia?

(2018) Twisha S. Patel et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Predisposing factors and outcome of uncommon yeast species-related fungaemia based on an exhaustive surveillance programme (2002–14)

(2017) Stéphane Bretagne et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Establishment and Use of Epidemiological Cutoff Values for Molds and Yeasts by Use of the Clinical and Laboratory Standards Institute M57 Standard

(2017) Shawn R. Lockhart et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Invasive infections due toSaprochaeteandGeotrichumspecies: Report of 23 cases from the FungiScope Registry

(2017) Luisa Durán Graeff et al.   MYCOSES

Magnusiomyces capitatus Peritonitis in a Child With Acute Lymphocytic Leukemia as a Breakthrough Infection During Caspofungin Therapy

(2017) Ayşe Bariş et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

The role of epidemiological cutoff values (ECVs/ECOFFs) in antifungal susceptibility testing and interpretation for uncommon yeasts and moulds

(2016) Ana Espinel-Ingroff et al.   REVISTA IBEROAMERICANA DE MICOLOGIA

Invasive Trichosporon Infection: a Systematic Review on a Re-emerging Fungal Pathogen

(2016) João N. de Almeida Júnior et al.   Frontiers in Microbiology

Invasive Candidiasis

(2015) Bart Jan Kullberg et al.   NEW ENGLAND JOURNAL OF MEDICINE

Use of Anidulafungin as a Surrogate Marker To Predict Susceptibility and Resistance to Caspofungin among 4,290 Clinical Isolates of Candida by Using CLSI Methods and Interpretive Criteria

(2014) Michael A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of rare invasive yeast infections

(2013) M.C. Arendrup et al.   CLINICAL MICROBIOLOGY AND INFECTION

Comparison of the Vitek 2 yeast susceptibility system with CLSI microdilution for antifungal susceptibility testing of fluconazole and voriconazole against Candida spp., using new clinical breakpoints and epidemiological cutoff values

(2013) Michael A. Pfaller et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Epidemiology, Antifungal Susceptibility, and Pathogenicity of Candida africana Isolates from the United Kingdom

(2013) Andrew M. Borman et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Echinocandin and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates Collected from 2010 to 2011: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance

(2013) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Molecular Identification, Antifungal Susceptibility Profile, and Biofilm Formation of Clinical and Environmental Rhodotorula Species Isolates

(2012) Jorge Meneses Nunes et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004–2008

(2012) Michael Pfaller et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B, Flucytosine, and Itraconazole and Candida spp. as Determined by CLSI Broth Microdilution

(2012) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Uncommon yeast infections in hematological patients: from diagnosis to treatment

(2011) Morena Caira et al.   Expert Review of Anti-Infective Therapy

Triazole and Echinocandin MIC Distributions with Epidemiological Cutoff Values for Differentiation of Wild-Type Strains from Non-Wild-Type Strains of Six Uncommon Species ofCandida

(2011) Michael A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Emerging opportunistic yeast infections

(2011) Marisa H Miceli et al.   LANCET INFECTIOUS DISEASES

Rapid Molecular Identification of Pathogenic Yeasts by Pyrosequencing Analysis of 35 Nucleotides of Internal Transcribed Spacer 2

(2010) A. M. Borman et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Susceptibility profile of clinical isolates of non-Cryptococcus neoformans/non-Cryptococcus gattii Cryptococcusspecies and literature review

(2010) Leticia Bernal-Martinez et al.   MEDICAL MYCOLOGY

BreakthroughSaprochaete capitatainfections in patients receiving echinocandins: case report and review of the literature

(2010) C. Schuermans et al.   MEDICAL MYCOLOGY

Bloodstream Infections Due to Trichosporon spp.: Species Distribution, Trichosporon asahii Genotypes Determined on the Basis of Ribosomal DNA Intergenic Spacer 1 Sequencing, and Antifungal Susceptibility Testing

(2009) T. C. Chagas-Neto et al.   JOURNAL OF CLINICAL MICROBIOLOGY

DisseminatedGeotrichum candiduminfection in a patient with relapsed acute myelogenous leukemia following allogeneic stem cell transplantation and review of the literature

(2009) T.J. Henrich et al.   Transplant Infectious Disease

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-Year Analysis of Susceptibilities of Noncandidal Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing

(2008) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY